COMPANY INFO
Outset, officially known as Outset.ai, is a software development company founded in 2022 by Aaron Cannon (co-founder and CEO), Molly Montgomery, and Michael Hess. It is headquartered in San Francisco, CA, and operates in the business/productivity software industry, specializing in AI-moderated research platforms that enable companies to conduct in-depth qualitative research at scale with AI-powered interviews and analytics. The company has about 11 to 12 employees and serves major enterprises like WeightWatchers, Nestle, and Microsoft, helping them gain deep customer insights quickly and efficiently through AI-driven interviews and usability testing.
Outset Medical, Inc. is a leading innovator in the personal products and medical device industry, founded in 2021 and headquartered in San Jose, California. With approximately 642 employees, Outset Medical, Inc. is renowned for its groundbreaking Tablo® hemodialysis system, empowering both acute care facilities and home dialysis programs with advanced technology designed to streamline the patient care experience. The company, led by CEO Leslie Trigg, is dedicated to transforming dialysis delivery for patients, providers, and healthcare systems.
Outset Medical, Inc. has taken a deliberate and innovation-driven approach to its funding strategy, resulting in a total of $21 million raised across two primary rounds. The company secured an initial seed round to support the launch and early development of its core product. This was followed by a significant Series A funding round aimed at accelerating team growth and deepening product capabilities, particularly in leveraging AI for research and product advancements. Outset Medical, Inc. has strategically partnered with leading venture capital investors, positioning itself for rapid expansion and ongoing research in the evolving healthcare technology landscape.
This Series A funding round was earmarked for expanding the team and accelerating product development to build advanced AI research agents, propelling Outset Medical, Inc.’s next phase of growth and technological advancement.
The seed round provided foundational capital for Outset Medical, Inc.’s initial product launch and early-stage development, supporting critical R&D milestones and go-to-market activities.
A renowned Silicon Valley venture capital firm, 8VC led the Series A round for Outset Medical, Inc. and is instrumental in supporting the company’s growth ambitions in AI-driven healthcare solutions.
Y Combinator played a significant role in the seed round, providing early-stage support and accelerator resources that helped shape Outset Medical, Inc.’s initial product strategy and go-to-market execution.
An active seed-stage investor, Ritual Capital contributed to the company’s first investment round, helping catalyze its entry into the market.
Participated in the seed round with critical funding and advisory support to bolster Outset Medical, Inc.’s R&D pipeline.
As a seed round investor, Rebel Fund brought domain expertise and early-stage capital to help validate the company’s technology and market fit.
Invested during the seed round, supporting the advancement of Outset Medical, Inc.’s innovative healthcare solutions and technology stack.
Joined other seed investors to provide foundational support during the earliest stage of Outset Medical, Inc.’s startup journey.
Provided ongoing support and strategic guidance as part of the company’s investment syndicate, leveraging Bain’s broad healthcare expertise.
Helped seed Outset Medical, Inc. through investment and mentorship, enabling access to a wide network of founders and operators.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Outset Medical, Inc. funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.